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A B S T R A C T
The process of intraocular lens (IOL) delivery within the capsular bag during cataract surgery is crucial, as
the integrity of the IOL, the injector and the ocular structures should be preserved at all times. This study
aims to obtain the main parameters that affect the injection force exerted in the ejection of an intraocular lens
(IOL) through syringe-type injectors. For that purpose, ejection tests were carried out in vitro, measuring the
resistance force throughout the entire delivery process. The effect of IOL material, haptic design, IOL thickest
area and ophthalmic viscosurgical device (OVD) was studied by ejecting seven IOLs with four syringe-type
injectors of different sizes, 3.0, 2.2 and 1.8 mm. In all injectors, plate hydrophilic IOLs present the lowest
resistance forces; hydrated C-loop hydrophobic IOLs present higher forces and the C-loop hydrophobic IOL in
dry conditions presents the highest resistance forces. All IOLs could be properly delivered with an injector size
of 2.2 mm, making injector sizes of 3.0 mm outdated. The injector size of 1.8 mm damaged several IOLs. IOL
material and cartridge nozzle size were the most influential parameters in IOL delivery. IOL thickest area was
also relevant but in a lesser extent whereas IOL haptic design was not as relevant.1. Introduction
Since the implantation of the first intraocular lens (IOL) by Ridley
(1952), the field of cataract surgery has been developing substantially.
From the use of flexible materials with different haptic designs in
the IOLs to the development of less invasive implantation devices,
important advances have improved the outcome of the surgery (Rahimy
et al., 2013; Cabeza-Gil et al., 2019; Remón et al., 2020; Ang et al.,
2020). Nowadays, one of the main goals of cataract surgery is focused
on the incisions, their size and location (Beltrame et al., 2002; Elkady
et al., 2009), in order to reduce the risk of suffering post-surgery
complications, like an infection from contamination (Nagaki et al.,
2003), and assure a faster recovery (Dewey et al., 2014). This aim has
promoted the development of new soft materials for the IOL, such as
hydrophobic and hydrophilic acrylate, together with the availability
of innovative surgical instruments as injectors and new foldable IOL
designs (Kodjikian et al., 2006).
Incision damage has been studied to depend on injection speed and
type (Ouchi, 2012; Allen et al., 2012). Currently, the most common
injector types are syringe and screw. The latter allows a constant
insertion speed, avoiding abrupt alterations in the delivery. However,
its mechanism requires the use of both hands. In contrast, syringe-type
injectors can be operated using only one hand, allowing surgeons to
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use the other hand to secure and stabilize the eye. The main limitation
of this design is that the force applied by the IOL delivery system needs
to be manually controlled and carefully balanced in order to minimize
possible complications in the cornea of the patient, by damaging the
IOL or the injection system in the delivery.
The main findings in literature focus on how the geometry of the
injector affects the corneal incision (Kohnen and Klaproth, 2008; Nana-
vaty and Kubrak-Kisza, 2017; Arboleda et al., 2019; Haldipurkar et al.,
2020). In terms of surgical outcomes, the insertion of the IOLs causes
enlargement of all corneal incision wounds (Kohnen and Klaproth,
2008; Arboleda et al., 2019; Haldipurkar et al., 2020). Nevertheless,
fast-speed IOL insertion, newer motorized injectors and new injector
designs have been shown to decrease the amount of wound enlarge-
ment caused by IOL insertion (Ouchi, 2012; Allen et al., 2012; Khokhar
et al., 2014; Tataru et al., 2015; Wang et al., 2016; Yamakawa et al.,
2017). Their most significant differences are the size of the nozzle, the
shape of the silicone cushion and the design of the lens cartridge, which
has shown to influence IOL ejection (Kleinmann, 2005; Marcovich,
2006). Furthermore, Kleinmann and Kleinmann (2014) designed a
finite element (FE) model for comparing stress induced on corneal
incisions during IOL implantation. However, to the best of our knowl-
edge, only two studies have evaluated the resistance force exertedvailable online 30 August 2021
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by the IOL delivery system (Bozukova et al., 2013; Usui and Tanaka,
2015). Bozukova et al. (2013) reported the maximum force needed to
inject 13 different IOLs in the ACCUJECT™ 2.2-1P syringe-type injector,
whereas Usui and Tanaka (2015) evaluated several IOL deliveries using
5 different syringe-type injectors. This resistance force is an interesting
in vitro marker, as high or unbalanced forces can lead to damage in the
IOL and poor surgery outcome.
This study was aimed to analyze the effect of IOL material, haptic
design and IOL thickest area, as well as the dimensions and shape
of the syringe-type injection system, in the resistance force exerted
in IOL delivery for cataract surgery. The influence of the ophthalmic
viscosurgical device (OVD) (Bissen-Miyajima, 2008) was also studied
by conducting tests with three different viscoelastic solutions.
2. Material & methods
2.1. Materials
The injection devices chosen for all the experiments of this study
were the ACCUJECT™ 3.0-1P , 2.2-1P, VISCOJECT™-BIO 2.2 (Medicel,
Switzerland) and BLUEMIXS®180 (Carl Zeiss Meditec AG, Germany),
four syringe-type injectors shown in Fig. 1. Seven different IOLs were
ejected in these injectors, see Fig. 2, and the resistance force exerted
by the system was measured.
Three hydrophilic IOL plate designs were tested, AT LISA (Carl Zeiss
Meditec AG, Germany), Y60 and LIOCAN (AJL Ophthalmic, Spain). The
AT LISA and Y60 models are quite similar in many ways: their haptic
design, overall diameter and thickest area, see Fig. 2. The LIOCAN
model shares the same shape as Y60 but with a bigger overall diam-
eter, 14.25 mm. Four hydrophobic IOLs were analyzed: a hydrophobic
double C-loop POD F GT (PhysIOL, Beaver-Visitec International, USA),
which has an overall diameter of 11.40 mm and has the lowest thickest
area of all IOLs under investigation, 0.65 mm; and three different
hydrophobic C-loop IOLs, two IOL prototypes that were designed in
a previous work (Cabeza-Gil et al., 2020), hereinafter referred to as
model #C and #D, and the AIALA model (AJL Ophthalmic, Spain),
see Fig. 2. All three C-loop IOLs have different designs of the haptics,
but they share the same overall diameter of 13.00 mm. Moreover,
the AIALA model has a lower thickest area than models #C and #D,
0.83 mm against 1.13 mm. A priori, model #C is considered a flexi-
ble C-loop design whilst the other two are considered stiffer designs,
according to their behavior in the standardized compression test ISO
11979-3 (Cabeza-Gil et al., 2019, 2020).
The optical power of all human IOLs tested was +22.0 diopters
(D) while the LIOCAN, a dog-intended IOL, was +41.0 D. The optic
thickness of the IOLs or its thickest area was measured with CellScale
MicroTester, see Supplemental Data file for further knowledge on the
technique used. All IOLs were kept submerged in a saline solution for
at least 72 h before the experiments to assure they were tested in a
hydrated state. Additionally, model #D was analyzed in a dry state,
i.e., not having been kept submerged before the tests, as a comparison
of the material behavior with and without water content. This was
performed as several ophthalmology companies offer the IOL preloaded
in the injector and not submerged in a saline solution.
The thickest area of the IOL is expected to have a large influence on
the force exerted by the injector due to the high compression stress to
which the IOL is subjected to when passing through the lens cartridge
and the nozzle. For this reason, seven different AT LISA models with an
optical power between 0.0 and 27.0 D, which implies a range of thickest
areas from 0.29 mm to 1.23 mm, were analyzed in the BLUEMIXS®180
njector, see Table 1, the one recommended for this IOL.
In all tests, the injector was filled with an OVD, as in clinical
nterventions. In order to observe the influence of this viscoelastic
olution, three different OVDs, AJL VISC 1.4%, AJL VISC 2.0% and
JL VISC 3.0% (AJL Ophthalmic, Spain)—percentages referring to the
mount of sodium hyaluronate they contain—were tested with model2
D IOL in the ACCUJECT™ 2.2-1P injector in dry conditions. a2.2. Experimental procedure
The tests consisted in a controlled displacement of the loading
pusher of the injector, replicating the IOL injection by the ophthalmol-
ogist, while the force needed in the ejection was recorded. The loading
pusher was displaced the total length of the loading pusher to assure
the ejection of the IOL, i.e., 42.5 mm for injectors ACCUJECT™ 2.2-1P,
.0-1P and BLUEMIXS®180 and 52.5 mm for injector VISCOJECT™-
IO 2.2, at a constant velocity of 4 mm/s, as supposed for clinical
alues (Allen et al., 2012). The IOLs were placed into their reference
onfiguration, without bending the IOL haptics as shown in Fig. 3. A
ideo of an IOL delivery in each injector is uploaded as Supplemental
ata to help the reader understand the process of the experiments.
The resistance force exerted by the IOL delivery system was mea-
ured and recorded using an Instron 5548 Electroplus Microtester with
50 N full-scale load cell, see Fig. 3, for all injectors under investiga-
ion. In the specific cases where 50 N were not enough to push the
OL through the nozzle, which happened only with BLUEMIXS®180
njector, a 250 N full-scale load cell was used. Finally, IOL resistance
orce to injection along the length of the injector was processed with
ATLAB 2020a (MathWorks, USA). To compare all results, an ANOVA
nalysis, considering a 𝑝𝑣𝑎𝑙𝑢𝑒 < 0.05 as significant, was performed.
All experiments were conducted at a temperature of 23.5±1 ◦C and
relative humidity of 28%. This setting is based on the conditions in
he operating room. A minimum of three tests were conducted for each
esting condition.
.3. Study design
The stages followed in this study are here described. Firstly, the
ffect on the resistance force in IOL delivery of the composition of the
VD was evaluated testing three different OVDs, AJL VISC 1.4%, AJL
ISC 2.0% and AJL VISC 3.0%, with injector ACCUJECT™ 2.2-1P and
odel #D in dry conditions.
Secondly, the effect of the IOL and the size of the injector was
nalyzed. To do so, every IOL under investigation was ejected in all four
njectors and the resistance force of the delivery was recorded. Fig. 2
hows all the IOLs that were ejected and Fig. 1 shows all the injectors
sed in the study. All tests were carried out using AJL VISC 1.4%. In
rder to isolate the effect of the IOL, control cases of all injectors were
reviously performed. These tests consisted in the ejection of the system
ithout any IOL, allowing to observe the forces exerted intrinsically by
he injectors. These tests were conducted for 2.50 mm more than the
jection tests, at the same constant speed of 4 mm/s, to monitor the
orce exerted by the injector itself, which is that of the silicone cushion
assing through the cartridge.
Thirdly, in order to compare the effect of the material exclusively,
ydrophobic and hydrophilic acrylate, two lenses without the haptics
only the spherical optic part) with the same optical power, +22.0 D,
nd therefore thickest area, but different materials were analyzed in
he ACCUJECT™ 2.2-1P injector. In this test, the effect of the haptic
eometry of the IOL is subtracted. Thus, it can also serve as control
est for the effect of the haptics in the delivery system.
Finally, the effect of the thickest area of the IOL, which is highly
orrelated with IOL optical power, was analyzed. For that purpose, all
T LISA IOLs described in Table 1 were tested in the BLUEMIXS®180
njector.
. Results
For a better understanding of the IOL delivery process, Fig. 4 shows
n example curve of the force exerted by the IOL delivery system to
escribe the most important regions throughout the delivery process. As
xample, the resistance force of the Y60 IOL ejected by the ACCUJECT™
.2-1P syringe-type injector is shown. The shape of this graph has been
ssured throughout the research to be representative of any IOL ejected
Journal of the Mechanical Behavior of Biomedical Materials 124 (2021) 104793I. Cabeza-Gil et al.Fig. 1. The syringe-type injectors ACCUJECT™ 3.0-1P, ACCUJECT™ 2.2-1P, VISCOJECT™-BIO 2.2 and BLUEMIXS®180 and their main characteristics are shown. All injectors share
the same silicone cushion, except for that of VISCOJECT™-BIO 2.2, which has a rounder shape. The shape of the silicone cushion is the same as the shape of the nozzle.Fig. 2. All the IOL models analyzed in the study. The material, the haptic design and the overall diameter of each IOL are shown. Moreover, the thickest area, which is the
maximum optic thickness, was measured since it is expected to be a relevant factor in the resistance force in the IOL delivery system. The optic diameter of all IOLs under
investigation is 6.00 mm, except for the LIOCAN model, which is 6.50 mm.Table 1
Diopters and thickest area (mm) of the different AT LISA IOLs tested in the BLUEMIXS®180 injector to evaluate the influence of the thickest area in ejection force.
AT LISA Power (D) +0.0 +3.5 +8.0 +12.5 +18.0 +22.0 +27.0
Thickest area (mm) 0.29 ± 0.02 0.48 ± 0.02 0.61 ± 0.02 0.74 ± 0.02 0.98 ± 0.02 1.16 ± 0.02 1.27 ± 0.02Fig. 3. IOL delivery system using an Instron 5548 Electroplus Microtester. A methacrylate tube was designed to place and fix the injector during IOL delivery. Figure shows the
placement of the IOL on the left and the process of delivery on the right.in a syringe-type injector. Four key regions can be highlighted in the
graph. Firstly, a peak force that appears approximately 9 mm after
starting to push the injector corresponds to the initial contact of the
loading pusher with the IOL. Subsequently, the IOL starts being dragged
and the applied force increases as the IOL and silicone cushion are
inserted into the lens cartridge. This occurs while the displacement of
the loading pusher is between 15 and 30 mm. Once they are in, the
force applied decreases gradually, as there are no abrupt changes in3
the cross-sectional area of the nozzle. At around 30 mm of displace-
ment of the loading pusher, the IOL reaches the tip of the injector,
the narrowest part of the nozzle, and for the next 8 mm the force
significantly increases as the IOL is driven out. This is the part of the
IOL delivery where the resistance force is the highest (not counting the
subsequent silicone cushion delivery) and thus, this is the force that
will be compared among all cases. It is also the most important part
of the delivery, as it is mostly at this moment when the IOL can be
Journal of the Mechanical Behavior of Biomedical Materials 124 (2021) 104793I. Cabeza-Gil et al.Fig. 4. Description of the IOL delivery process. Resistance force of the Y60 IOL through
the ACCUJECT™ 2.2-1P injector. All syringe-type injectors under investigation follow
the same pattern in the resistance force exerted.
Fig. 5. Study of the effect of OVD composition in IOL delivery (model #D in dry
conditions) by means of the resistance force using three different sodium hyaluronate
concentrations, AJL visc 1.4% (red), AJL visc 2% (blue) and AJL visc 3% (green). All
cases were reproduced three times (n = 3).
damaged or erratically delivered. The process of IOL delivery would
already be finished by this point. However, for this example graph, the
following displacement of the silicone cushion through the tip and its
eventual ejection are shown. It can be noted that the ejection force rises
considerably, even more than for the IOL delivery, as the cushion is
wider and less lubricated. In the following graphs, except for the control
cases, the delivery of the cushion has been removed as it has no clinical
interest.
3.1. Effect of OVD
The three different OVDs object of this study were compared by
means of ejecting model #D in dry conditions with ACCUJECT™ 2.2-
1P injector, see Fig. 5. It seems that the higher the sodium hyaluronate
concentration, the lower the force exerted by the IOL delivery system.
However, there is no statistically significant difference in the maximum
resistance force (𝑝𝑣𝑎𝑙𝑢𝑒 > 0.05) among the different viscoelastic solu-
tions. From these results, the remaining tests were decided to be carried
out with the AJL VISC 1.4%.4
3.2. Effect of IOL delivery and injector size
Before testing the lenses on both injectors, a control assay, i.e., with-
out any IOL, was performed to evaluate the resistance force exerted by
each injector itself, see Fig. 6A. The maximum force obtained at the
end of the pusher displacement and the resistance force when the IOL
would be driven out – at around 30 mm as commented above – are
shown in Table 2.
The comparison between the forces exerted by the different IOLs
under investigation for the ACCUJECT™ 3.0-1P is presented in Fig. 6B
and Table 3. All cases can be differentiated into 4 groups, regarding
the force exerted by the ejection of the IOL, that match the differ-
ences in IOL material and IOL thickest area: model #D (dry), which
unsurprisingly presented the highest force exerted, 15.78 ± 2.00 N;
models #D (submerged) and #C, two C-loop hydrophobic designs,
presented an average of force 7.19 and 7.76 N; the models AIALA and
POD F GF, hydrophobic designs with a lower thickest area, presented
a slightly lower average force than models #D (submerged) and #C,
4.82 and 4.84 N; and the hydrophilic plate designs, AT LISA, Y60 and
LIOCAN, presented the lowest average force of 3.51, 3.71 and 2.68 N,
respectively. For graphical purposes and due to their similar behavior
with models #D and AT LISA, respectively, models #C and Y60 are
not plotted in Fig. 6. Their graphs can be observed in the Supplemental
Data file.
Fig. 6C and D show the force exerted by the IOLs under investigation
when ejected by the injector ACCUJECT™ 2.2-1P and VISCOJECT™-
BIO 2.2. Again, the same trend referring to the difference in behavior
according to IOL material and IOL thickest area was observed. The
maximum forces and their corresponding deviations for each IOL are
gathered in Table 3.
Fig. 6E shows the force exerted by model #D (submerged), POD
F GF and AT LISA when ejected by the BLUEMIXS®180. The other
IOLs are not included as they were macroscopically damaged in the
delivery process. The same trend as in the other injectors is obtained.
However, the average forces are notably higher. Model #D (submerged)
presented the highest force, 78.29 ± 14.67 N, followed by the POD F GF
IOL, with 36.78 ± 1.96 N and finally by the AT LISA IOL, 25.88 ± 2.02
N The resistance force in the IOL delivery process for the damaged IOLs
is presented in the Supplemental Data file.
3.3. Effect of IOL material: delivery of the optic part
In order to verify the influence of the material, the hydrophobic
and hydrophilic acrylic material under in vivo conditions (hydrated)
were compared in the ACCUJECT™ 2.2-1P injector. The haptics were
carefully removed from the IOLs to test only the optic of +22.0 diopters
and same diameter (6 mm), subtracting the effect of the geometry.
Fig. 7A shows the resistance force for the two optics with different
materials. The maximum resistance force for the hydrophobic acrylate
is considerably higher, 14.29 ± 2.47 N, compared to the maximum
resistance force for the hydrophilic acrylate (HEMA), 5.83 ± 1.83 N.
3.4. Effect of IOL thickest area
Lastly, the influence of the thickest area of the IOLs was analyzed by
means of testing AT LISA IOLs with an optical power range between 0.0
and 27.0 D in the BLUEMIXS®180 injector, see Fig. 7B. For graphical
purposes, some IOLs have not been plotted, see Supplemental Data file.
The IOL barely exerted resistance force up to an IOL optical power of
8.0 D, which corresponds to a thickest area of 0.61 mm, see Table 1.
With this IOL, the maximum force was 17.83 ± 2.93 N. A similar
resistance force was obtained for the IOL with an optical power of 12.5
D and 0.74 mm of thickest area. The following significant change is for
the IOL of 18.0 D, 0.98 mm of thickest area, with a maximum force
of 22.74 ± 1.93 N. Finally, a similar resistance force was obtained for
the IOLs with 22.0 and 27.0 D, 1.16 and 1.27 mm in thickest area
respectively, of 25.82 ± 3.14 N
Journal of the Mechanical Behavior of Biomedical Materials 124 (2021) 104793I. Cabeza-Gil et al.Fig. 6. A. Resistance force (N) of the four syringe-type injectors under investigation, the ACCUJECT™ 3.0-1P and 2.2-1P, the VISCOJECT™ and the BLUEMIXS®180, without the
ejection of an IOL (n = 5 for all cases). IOLs delivery in the ACCUJECT™ 3.0-1P injector B., in the ACCUJECT™ 2.2-1P injector, C. in the VISCOJECT™ 2.2 injector, D., and in the
BLUEMIXS®180, E., for the different IOLs analyzed: model #D dry (n = 6) and hydrated (n = 5), model #C (n = 5), AIALA (n = 5), AT LISA (n = 5), Y60 (n = 5) and LIOCAN
(n = 6). Some videos of the IOL delivery process for each injector under investigation are uploaded as Supplemental Data.Table 2
Maximum force (N) exerted by the injector itself and the resistance force of each injector when the IOL would be driven out for the four
syringe-type injectors under investigation.
ACCUJECT™ 3.0-1P ACCUJECT™ 2.2-1P VISCOJECT™ BLUEMIXS®180
Maximum force 11.16 ± 7.16 22.24 ± 8.18 29.24 ± 7.45 40.49 ± 3.62
Contributed force in IOL delivery 0.85 ± 0.11 2.95 ± 0.58 9.20 ± 2.63 14.71 ± 1.864. Discussion
The resistance force exerted by an IOL injection system is an inter-
esting in vitro marker for comparing the mechanical effect of material,
geometry and injection device in the delivery of the IOL. It can give
an insight in the adequacy of certain conditions, considering that high
resistance forces are undesirable as they can damage the IOL or the
delivery system during implantation, as well as complicate a controlled
and balanced ejection. Therefore, in this study, the force needed to
deliver IOLs with different conditions and in different injectors was5
obtained and compared, in order to evaluate the effect of geometry,
optical power (related to the IOL thickest area) and material of the IOL,
as well as injector size, in the delivery.
This study has obtained clear evidence of the influence of IOL
material, nozzle diameter of the injector and IOL thickest area in the
IOL delivery process. The importance of a proper hydration of the
IOLs has also been proven by testing the same C-loop hydrophobic
IOL, model #D, being or not hydrated before the tests. When the IOL
was tested dry, the force needed to eject it was notably higher and
thus, the chances of IOL damaging increased significantly, see Fig. 6,
Journal of the Mechanical Behavior of Biomedical Materials 124 (2021) 104793I. Cabeza-Gil et al.Table 3
Maximum force (N) applied for each IOL and injector under investigation. The force expressed in the Table is the peak force when the IOL is
driven out.
ACCUJECT™ 3.0-1P ACCUJECT™ 2.2-1P VISCOJECT™-BIO 2.2 BLUEMIXS®180
Model #D (dry) 15.78 ± 2.00 24.48 ± 3.19 Damaged –
Model #D (submerged) 7.76 ± 1.74 16.26 ± 3.01 32.89 ± 5.49 78.29 ± 14.67
Model #C 7.19 ± 1.44 15.55 ± 1.55 34.38 ± 3.02 –
AIALA 4.82 ± 0.53 12.25 ± 2.05 22.45 ± 1.97 Damaged
POD F GF 4.84 ± 1.76 13.79 ± 1.81 23.82 ± 1.01 36.78 ± 1.96
AT LISA 3.51 ± 0.27 7.42 ± 1.00 12.78 ± 0.96 25.88 ± 2.02
Y60 3.71 ± 1.25 6.52 ± 0.95 14.03 ± 4.14 Damaged
LIOCAN 2.68 ± 1.22 6.00 ± 0.91 12.26 ± 2.46 DamagedFig. 7. A. Comparative between the delivery of the optic part of the IOL (+22.0 D, without the haptics) for hydrophobic and hydrophilic acrylate. All cases were reproduced
three times (n = 3). B. Resistance force for several AT LISA IOLs with a different optical power range [0.0 – 27.0 D], which is related to IOL thickest area (n = 5 for all tests
conducted).which in fact happened with some injectors, see Table 3. The resistance
forces obtained could be differentiated into 4 groups, depending on
the state or type of material of the IOLs and the IOL thickest area:
model #D, hydrophobic acrylate in dry state, which presented the
highest resistance force; models #D and #C; POD F GF and AIALA
IOLs, all hydrophobic acrylate in hydrated state; and AT LISA, Y60
and LIOCAN, all hydrophilic acrylate plate designs in hydrated state,
which presented the lowest resistance forces. The same trend was
confirmed for all injectors under investigation, ACCUJECT™ 2.2-1P,
3.0-1P, VISCOJECT™-BIO 2.2 and BLUEMIXS®180, see Fig. 6. These
behaviors lead to the conclusion that the hydrophobic acrylate has
different mechanical properties in the dry and hydrated state. Further
material tests can be carried out to confirm this conclusion. Addition-
ally, the effect of IOL material was verified testing the same optics, one
made of hydrophobic and the other of hydrophilic acrylate. These tests
confirmed the high effect of the material in the resistance force, as the
hydrophobic optic produced a force of 14.29 N, more than twice as
much as the hydrophilic one, which resulted in 5.83 N. These results
were similar to the forces obtained in the tests of the IOLs with the
same material and optics, models #C and #D submerged and Y60,
respectively.
Therefore, it could be said that haptic design barely influences the
force exerted, see Fig. 6, and Fig. 7A. This can be explained considering
that the force required to push the IOL through the cartridge depends
on the relationship between the diameter of the cartridge nozzle and
the volume of the IOL in its thickest area. Since the haptics are not a
part of the thickest area of the IOL, this explains why the IOL haptic
has no relevant importance in the determination of the force required
to push the IOL. This trend was also confirmed in the similarity of the
resistance force exerted by models #D and #C, two different C-loop
hydrophobic models, and the different plate hydrophilic designs, AT
LISA and Y60, see Supplemental Data file.
As a clear verification of the influence of the thickest area of the
IOLs, model AT LISA with different optical powers, and thus different
thickest area measurements, was tested in injector BLUEMIXS®180.6
With these tests, the high correlation between the thickest area and
the resistance force was verified, see Fig. 7B.
In this study, few IOLs were damaged in the tests, all happening
in injector BLUEMIXS®180, which has the lowest nozzle size, 1.8 mm,
and model #D (dry) in injector VISCOJECT™-BIO 2.2. Only models #D
(hydrated), POD F GF and AT LISA were suitable to be tested correctly
in the BLUEMIXS®180 injector, see Table 3. The rest of the IOLs were
damaged in the delivery process with this injector. Surprisingly, the
Y60 IOL, similar to AT LISA, was damaged in this injector whilst
AT LISA was not. It is likely that the hydrophilic material of both
lenses was not completely the same. In screening tests, which were
not included in the study, some IOLs were damaged when they were
misplaced in the lens cartridge. IOLs with no apparent breakage were
checked in an optical microscope to observe any internal damage. It
was not observed in any case.
The present study has also shown that the injector size of 3.0 mm
is outdated and that even IOLs such as LIOCAN, a dog-purpose IOL,
could be implanted in injectors of 2.2 mm. Moreover, observing the
resistance force exerted by model #D in dry state, it is recommended
for IOL manufacturers to preload the IOL in a saline solution.
The importance of the injector in the resistance force of the system
can be checked when comparing the different results in Fig. 6 and
Table 3. For injector BLUEMIXS®180, the resistance forces are higher
as the diameter of the tip is smaller, resulting in a higher force to push
the IOL through the nozzle. This is less desirable. However, a smaller
nozzle implies a smaller incision size in the cornea (Arboleda et al.,
2019; Haldipurkar et al., 2020; Oshika and Wolfe, 2019). Therefore,
a compromise should be reached between the incision size and the
proper IOL delivery. The relevance of the injector was also shown in
the study of Usui and Tanaka (2015). In their case, the values of force
range from 2 to 20 N for injector with a nozzle diameter higher than
2.2 mm, similar to the results obtained in our tests.
In this study, the same syringe-type injector as Bozukova et al.
(2013), ACCUJECT™ 2.2-1P, was used. The resistance forces obtained
for IOL ejection in this study are similar to what Bozukova et al.
Journal of the Mechanical Behavior of Biomedical Materials 124 (2021) 104793I. Cabeza-Gil et al.obtained. However, the test method was different, as they used a
loading–unloading cycle. The maximum resistance force in the control
assay – the injection without any IOL – of Bozukova et al. was of 13
N against the 22.24 N obtained in this study for a displacement of the
pusher of 45 mm. If the pusher in this study had been displaced only
1 mm less, the maximum resistance force would be of around 13 N.
Therefore, the results can be assumed comparable.
One of the limitations of the study was that the tests were conducted
in an air filled chamber instead of a fluid filled chamber that would
mimic natural environment. Usui and Tanaka (2015) performed these
tests in a porcine eye and in a plastic dish and they obtained that the
forces in the plastic dish were slightly lower. Another limitation might
be the few trials conducted per sample that could have influenced the
OVD conclusion. Moreover, further investigations could study the effect
of injector material, as more flexible nozzles are expected to enlarge
with IOL ejection and therefore require less injection force.
This study has added some light to the effect of IOL characteristics
in the delivery. The importance of a well preserved and hydrated IOL
prior to use has been demonstrated. Furthermore, the minor effect
of the composition of the viscoelastic solution was shown. Finally,
the material of the IOL, the injector size and the IOL thickest area
were key factors in the resistance force exerted by the system. When
comparing to literature, the importance of the delivery device was
made clear. Nevertheless, a compromise between the resistance force
and the incision size must be met when selecting the adequate injector.
5. Conclusions
The shape of the resistance force curves throughout the entire
ejection process of an IOL with a syringe-type injector is explained
in this work. The IOL material is key in the IOL delivery, being the
hydrophilic acrylate the one that produces smaller forces. Moreover,
hydrophobic IOLs are recommended to be hydrated before implantation
as dry IOLs present higher resistance forces and thus higher probability
of damage. Injector sizes of 3.0 mm are outdated. No hydrated IOL was
apparently damaged with an injector size of 2.2 mm.
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